Paul A Grayburn

Author PubWeight™ 82.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003 11.88
2 Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009 3.00
3 Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 2007 2.19
4 Thinking outside the "box"-the ultrasound contrast controversy. J Am Coll Cardiol 2007 2.06
5 Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003 2.03
6 Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 2002 1.98
7 Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012 1.91
8 Echocardiographic indices do not reliably track changes in left-sided filling pressure in healthy subjects or patients with heart failure with preserved ejection fraction. Circ Cardiovasc Imaging 2011 1.86
9 Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005 1.61
10 A suggested roadmap for cardiovascular ultrasound research for the future. J Am Soc Echocardiogr 2011 1.60
11 Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A 2006 1.57
12 Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003 1.54
13 Established preoperative risk factors do not predict long-term survival in isolated coronary artery bypass grafting patients. Ann Thorac Surg 2012 1.44
14 Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation. Am J Cardiol 2013 1.43
15 Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 2005 1.23
16 DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol 2002 1.22
17 Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol 2005 1.19
18 Valvular heart disease: aortic regurgitation. Circulation 2005 1.19
19 Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol 2003 1.15
20 Mitral "annular" calcium forming a complete circle "O" causing mitral stenosis in association with a stenotic congenitally bicuspid aortic valve and severe coronary artery disease. Am J Geriatr Cardiol 2006 0.96
21 Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography 2002 0.96
22 Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST). Circulation 2003 0.95
23 Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle 2012 0.92
24 Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults. Am J Cardiol 2005 0.90
25 Non-invasive coronary angiography using multislice computed tomography. Heart 2005 0.90
26 In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia 2015 0.89
27 Grading severity of mitral regurgitation by echocardiography: science or art? JACC Cardiovasc Imaging 2010 0.88
28 Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol 2013 0.88
29 Relation of obesity to atrial fibrillation after isolated coronary artery bypass grafting. Am J Cardiol 2008 0.86
30 Preoperative visualization of a muscular ventricular septal defect by 64-slice cardiac computed tomography. Proc (Bayl Univ Med Cent) 2008 0.85
31 Dramatic RV volume reduction following atrial septal defect closure demonstrated by multi-slice CT volume rendering. Clin Cardiol 2006 0.85
32 Measurement of right ventricular volumes before and after atrial septal defect closure using multislice computed tomography. Am J Cardiol 2007 0.85
33 Advances in the assessment of no-reflow after successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: now that we can diagnose it, what do we do about it? J Am Coll Cardiol 2008 0.84
34 Drug and gene delivery and enhancement of thrombolysis using ultrasound and microbubbles. Cardiol Clin 2004 0.84
35 Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. Circ Cardiovasc Imaging 2013 0.83
36 Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol 2013 0.83
37 Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol 2004 0.83
38 Comparing long-term survival between patients undergoing off-pump and on-pump coronary artery bypass graft operations. Ann Thorac Surg 2011 0.83
39 Islet purification method using large bottles effectively achieves high islet yield from pig pancreas. Cell Transplant 2012 0.83
40 Effect of body mass index on risk of long-term mortality following coronary artery bypass grafting. Am J Cardiol 2006 0.83
41 Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration). Am J Cardiol 2008 0.82
42 Color flow imaging of the vena contracta in mitral regurgitation: technical considerations. J Am Soc Echocardiogr 2003 0.82
43 Ischemic and functional mitral regurgitation in heart failure: natural history and treatment. Curr Cardiol Rep 2014 0.82
44 Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol 2004 0.81
45 Ultrasound contrast agents: balancing safety versus efficacy. Expert Opin Drug Saf 2009 0.81
46 Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr 2010 0.80
47 Assessment of low-gradient aortic stenosis with dobutamine. Circulation 2006 0.80
48 Potential bioeffects of ultrasonic destruction of microbubble contrast agents. J Am Coll Cardiol 2006 0.80
49 Effect of Optison on pulmonary artery systolic pressure and pulmonary vascular resistance. Am J Cardiol 2013 0.80
50 Stress echo without the stress: detection of coronary stenosis at rest by myocardial contrast echocardiography. Circulation 2005 0.79
51 A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging 2010 0.79
52 Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). J Card Fail 2007 0.79
53 Risk of death in heart disease is associated with elevated urinary globotriaosylceramide. J Am Heart Assoc 2014 0.79
54 Imaging of low-gradient severe aortic stenosis. JACC Cardiovasc Imaging 2013 0.79
55 Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Am J Cardiol 2007 0.79
56 Improvement of collagenase distribution with the ductal preservation for human islet isolation. Islets 2012 0.78
57 Improvement of porcine islet isolation by inhibition of trypsin activity during pancreas preservation and digestion using α1-antitrypsin. Cell Transplant 2012 0.78
58 Dobutamine challenge for low-gradient aortic stenosis. Circulation 2002 0.77
59 Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle 2012 0.77
60 Chest pain in an adolescent. Proc (Bayl Univ Med Cent) 2003 0.75
61 Diagnosing cardiac sarcoidosis clinically without tissue confirmation. Proc (Bayl Univ Med Cent) 2009 0.75
62 Usefulness of serial brain natriuretic peptide measurements for managing aortic valve stenosis in pregnancy. Proc (Bayl Univ Med Cent) 2009 0.75
63 Congenital pulmonic stenosis in a 77-year-old woman successfully treated with percutaneous balloon valvuloplasty. Proc (Bayl Univ Med Cent) 2010 0.75
64 Pacemaker laser lead extraction and reimplantation of dual-chamber implantable cardioverter defibrillator via Mustard baffle in complete transposition of great arteries. Proc (Bayl Univ Med Cent) 2010 0.75
65 An effective purification method using large bottles for human pancreatic islet isolation. Islets 2012 0.75
66 Improved surgical outcome for chronic severe aortic regurgitation with severely depressed left ventricular systolic function. J Am Coll Cardiol 2007 0.75
67 New concepts in functional mitral regurgitation: it is not just a disease of the left ventricle. J Am Coll Cardiol 2013 0.75
68 The importance of regurgitant orifice shape in mitral regurgitation. JACC Cardiovasc Imaging 2011 0.75
69 Acute myocardial infarction at 25 years of age. Proc (Bayl Univ Med Cent) 2004 0.75
70 Reply: When to Call It Severe Mitral Regurgitation? J Am Coll Cardiol 2015 0.75
71 Diastolic left main coronary flow reversal as a marker of severe aortic regurgitation. Tex Heart Inst J 2012 0.75
72 A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1. Hum Gene Ther Methods 2014 0.75
73 Necropsy findings early after transcatheter aortic valve implantation for aortic stenosis. Am J Cardiol 2012 0.75
74 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 2017 0.75
75 Carcinoid heart disease without the carcinoid syndrome but with quadrivalvular regurgitation and unsuccessful operative intervention. Am J Cardiol 2011 0.75
76 Best clinical trials reported in 2010. Am J Cardiol 2011 0.75
77 Effect of Elliptical LV Outflow Tract Geometry on Classification of Aortic Stenosis in a Multidisciplinary Heart Team Setting. JACC Cardiovasc Imaging 2017 0.75
78 Sudden onset of "cardiac" symptoms, (?) mild or severe aortic valve stenosis involving a congenitally bicuspid aortic valve, and nearly normal coronary arteries in an octogenarian. Am J Geriatr Cardiol 2006 0.75
79 The heaviest known operatively-excised aortic valve. Am J Cardiol 2006 0.75
80 Comparison of successful and failed alcohol septal ablations for obstructive hypertrophic cardiomyopathy. Am J Cardiol 2003 0.75
81 Percutaneous closure of multiple atrial septal defects with three Amplatzer septal occluder devices. Catheter Cardiovasc Interv 2004 0.75
82 Contrast guided two-dimensional echocardiography for needle localization during pericardiocentesis: a case report. J Am Soc Echocardiogr 2010 0.75
83 Effectiveness of Medical Therapy for Functional Mitral Regurgitation in Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol 2020 0.75
84 Relation of echocardiographic wall motion score index and response to dobutamine stress to defibrillation threshold at the time of implantation of a cardiac defibrillator. Am J Cardiol 2005 0.75